Recent Articles from GlobeNewswire

PETACH TIKVA, Israel, July 01, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced a clinical and educational collaboration with Keiser University, Florida’s largest private, non-profit university.

Report identifies what separates leaders from laggards in AI-powered PIM

Tilray Brands Announces Independence Day Parties Across the U.S.

Miami, FL, July 01, 2025 (GLOBE NEWSWIRE) -- Safe and Green Development Corporation (NASDAQ: SGD) ("SGD" or the “Company”) is pleased to announce the results of two independent appraisals conducted by CBRE Group, Inc. (“CBRE”), a global leader in commercial real estate services, for its properties in Lago Vista, Texas and Durant, Oklahoma.

New Brand Reflects Growing Demand For Permissioned, First-Party Consumer Data

RESTON, Va., July 01, 2025 (GLOBE NEWSWIRE) -- Ecuador’s border control authorities have significantly enhanced their identity verification capabilities by deploying a suite of advanced document examination devices from Regula. The nationwide upgrade, supported by the International Organization for Migration (IOM) and local partner INSETK, brings automation, precision, and speed to the country’s border checkpoints, which collectively process nearly 1.5 million travelers annually.

NORWELL, Mass., and ZÜRICH, Switzerland, July 01, 2025 (GLOBE NEWSWIRE) -- DIH HOLDING US, Inc. (“DIH”) (NASDAQ:DHAI), a global provider of advanced robotic devices used in rehabilitation, which incorporate visual stimulation in an interactive manner to enable clinical research and intensive functional rehabilitation and training in patients with walking impairments, reduced balance and/or impaired arm and hand functions, today announced the appointment of Rehazentrum Valens, a member of the Kliniken Valens group, as a DIH Center of Excellence. Through this partnership, DIH and the Kliniken Valens group reinforce their commitment to transforming rehabilitation by leveraging innovation to improve patient outcomes and support the recovery journey.

Media ReleaseCOPENHAGEN, Denmark; July 1, 2025

Portage, Michigan, July 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its second quarter of fiscal year 2025 on Thursday, July 31, 2025.  A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company’s second quarter that ended June 30, 2025.

Clinical Data Studio has supported 465 global studies since its launch in 2024, reducing data review cycles by up to 80% and accelerating patient profile reviews by 50%

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended June 30, 2025 on Tuesday, August 5, 2025 after the close of the financial markets.

In the independent analyst report, Sphera was named a leader in ESG and sustainability technology

U.S.-Based Production Partnership Accelerates OEM Alignment as $15.6B Smart Glass Automotive Market Set to Triple by 2030

SAN FRANCISCO and BERLIN, July 01, 2025 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing T cell receptor (TCR) engineered T cell therapies (TCR-T) to fight cancer, today announced the appointment of Christoph Broja, a Partner at EQT Life Sciences, to its Board of Directors.

BRIDGEWATER, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Synchronoss Technologies, Inc. (“Synchronoss”) (NASDAQ: SNCR), a global leader and innovator in personal cloud platforms, today announced that the company has joined the Russell 2000® Index, effective upon the U.S. market open on June 30, 2025.

Tireless advocate for 9-1-1 and public safety will guide Intrado’s advancement of industry standards and help define the future of emergency response

Reiterates openness and ongoing efforts to reach constructive compromise with Findell

One Winner Per Town Will Get Their Face on a Billboard—Plus Beer, Merch & Bragging Rights

The largest local REALTOR® Association in the state of Indiana contracts to make FOREWARN services available for its approximately 10,000 real estate professional members to promote proactive agent safety

IRVINE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, is pleased to announce the appointment of Shinya Inoue as Chief Marketing Officer (CMO), effective July 1, 2025.

Aptose will trade under the ticker symbol APTOF and begin trading on OTCQB today, July 1st

SYDNEY, July 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) today announced the appointment of Anthony Lewis as Chief Capital Officer, a newly established role responsible for overseeing the Company’s capital markets activity.

CHICAGO, July 01, 2025 (GLOBE NEWSWIRE) -- VelocityEHS, the global leader in EHS solutions and the pioneer in applying practical AI to workplace safety, today announced the release of AI PSIF Insights, a new feature within the company’s award-winning Incident Management solution on the VelocityEHS Accelerate® Platform. The feature leverages machine learning (ML) to uncover high risks companies carry forward hidden in “near miss” and other "minor" events, also known as Potential Serious Injuries and Fatalities (PSIFs) before they lead to life-altering harm.

PURCHASE, N.Y., July 01, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study surpasses 50% enrollment. The START Study is being conducted with partners at the Alzheimer’s Clinical Trials Consortium (ACTC), with $81 million in grant support from the National Institute of Aging (NIA) at the National Institutes of Health.

SEATTLE, July 01, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, and Flatiron Health, a leading healthtech company dedicated to expanding the possibilities of point-of-care solutions in oncology, today announced the integration of Adaptive’s clonoSEQ® test for measurable residual disease (MRD) assessment in lymphoid malignancies into OncoEMR®, Flatiron’s cloud-based Electronic Medical Record (EMR) platform.

MURRAY, Utah, July 01, 2025 (GLOBE NEWSWIRE) -- FinWise Bancorp (NASDAQ: FINW) (“FinWise” or the “Company”), the parent company of FinWise Bank, today announced that it will report its second quarter 2025 results and host a conference call and webcast after the market close on Thursday, July 24, 2025.

TWL Miner, a UK-based cloud mining platform established in 2019, has announced the successful completion of its Series B funding round, securing $95 million to support the integration of artificial intelligence technologies into its cloud mining operations.

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 30, 2025 to its short form base shelf prospectus dated May 15, 2025

Abeona will receive a license payment and potential development, regulatory, and sales milestones, and royalties

HARTSVILLE, S.C., July 01, 2025 (GLOBE NEWSWIRE) -- Sonoco Products Company (“Sonoco” or the “Company”)(NYSE: SON), a global leader in high-value sustainable packaging, will announce second quarter 2025 results on Wednesday, July 23, 2025, after the market closes. The Company will host a conference call to discuss these results on Thursday, July 24, 2025, at 9:00 a.m. Eastern Time.

TINA.org Files Complaint against Window Company with FTC

Landmark partnership will democratize access to critical eye treatment for millions facing preventable blindness from diabetes complications

CLEVELAND, July 01, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it has granted equity awards to new non-executive employees who joined the Company. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).

Divestiture Sharpens Portfolio, Enhances Capital Utilization, and Advances Growth Priorities

Establishes Digital Computing Division to Drive Company’s Digital Infrastructure Strategy,Adds Hash Rate of 3.11 EH/s, Expects Significant Bitcoin Mining Revenue, Sets Stage for Future High-Performance Computing (HPC) and AI-driven Entertainment Services Opportunities

LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (‘Marex’ or the ‘Group’; NASDAQ: MRX), the diversified global financial services platform, today announces that it has completed the acquisition of foreign exchange (FX) specialist Hamilton Court Group. The acquisition expands the Group’s FX offering, bringing new capabilities onto the platform, consistent with its strategy to diversify earnings.

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation (“Prospect”) (NASDAQ: PSEC) has announced the closing of the acquisition of QC Holdings, Inc. (“QC Holdings”), a provider of consumer credit, by Prospect on June 30, 2025. In accordance with the previously announced definitive merger agreement, Prospect has acquired QC Holdings in an all-cash transaction for a total enterprise value of approximately $115 million.

Press Release

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced AMAROQ MINERALS LTD. (TSX-V: AMRQ; AIM: AMRQ; XICE: AMRQ; OTCQX: AMRQF), an independent mine development corporation, has qualified to trade on the OTCQX® Best Market. AMAROQ MINERALS LTD. upgraded to OTCQX from the Pink® market.

The tokenization initiative would be made in connection with a real estate project with a projected sales revenue exceeding US$400 million

WALTHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced a capped royalty purchase agreement with Sobi® under which Apellis will receive up to $300 million in exchange for 90% of Apellis’ future ex-U.S. royalties for Aspaveli® (systemic pegcetacoplan). Under the companies’ 2020 collaboration agreement, Apellis is eligible for tiered royalties on ex-U.S. sales of Aspaveli ranging from high teens to high twenties. Apellis retains exclusive commercialization rights for systemic pegcetacoplan in the United States, where the product is marketed as EMPAVELI®.

For Its Fifth Annual Collectors Art Series, Breckenridge Distillery Partners with Visionary Artist to Create Label for Its New Calvados Cask Release

LONDON and PHILADELPHIA, July 01, 2025 (GLOBE NEWSWIRE) -- Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs, today announces the appointment of David Liebowitz, M.D., Ph.D. as Chief Medical Officer (CMO) and Yulii Bogatyrenko as an advisor in business development. Dr. Liebowitz will lead the Company’s clinical strategy and execution as it continues to advance its pipeline of targeted cancer therapies and Mr. Bogatyrenko will add additional strength to the Group’s business development strategy.

Collaboration merges arcade innovation with destination hospitality to fuel guest experiences and mutual growth

ATLANTA, July 01, 2025 (GLOBE NEWSWIRE) -- Gray Media has named Stephanie Plant as the next General Manager of WTAP, the NBC affiliate in Parkersburg, West Virginia. She will also oversee 2 local low-power stations: FOX affiliate WOVA-LD and CBS affiliate WIYE-LD. She succeeds Ken Long, who is retiring after 44 years in the media industry. Stephanie assumes her new role effective July 2, 2025.

SAN FRANCISCO and VANCOUVER, British Columbia, July 01, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“Jade”) (Nasdaq: JBIO), a biotechnology company focused on developing best-in-class therapies for autoimmune diseases, today announced the appointment of Brad Dahms as Chief Financial Officer.

This news release constitutes a “designated news release” for the purposes of the Company’s second amended and restated prospectus supplement dated December 17, 2024, to its short form base shelf prospectus dated November 10, 2023.

– Verrica to receive a $8 million milestone payment for initiation of the global study in July 2025, ahead of previous schedule –

ORLANDO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), has been added as a member of the Russell Microcap, Russell Microcap Growth, Russell 3000E and Russell 3000E Growth Indexes, as part of the 2025 Russell indexes reconstitution.

PRINCETON, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Close-Up International, a global leading provider of CRM and data technology solutions for the life sciences industry is pleased to announce the appointment of Jim Barone as Executive Vice President of Business Solutions. In this role, Jim will lead efforts to expand Close-Up’s footprint across the U.S. CRM market and drive strategic growth initiatives.

Transition to U.S. reporting status to take effect on January 1, 2026

- Sanofi to exercise option on third SAFEbody discovery program and sponsor combination clinical trial with muzastotug

Singapore , July 01, 2025 (GLOBE NEWSWIRE) -- YY Group Holding Limited (NASDAQ: YYGH) (“YY Group,” “YYGH,” or the “Company”), a global leader in on-demand workforce solutions and integrated facility management (IFM), is pleased to announce its acquisition of Pesticide Pest Control Pte. Ltd., a Singapore-based pest control company with over 30 years of operational history.

DURHAM, N.C., July 01, 2025 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry, today announced two Food and Drug Administration (FDA) luminaries have joined Parexel’s Consulting team – Lola Fashoyin-Aje, M.D., MPH, as Senior Vice President, Head of Regulatory Oncology, Cell & Gene, and Tala Fakhouri, Ph.D., MPH, as Vice President Consulting, AI & Digital Policy, Real-World Research. These strategic appointments further bolster the company’s industry-leading regulatory expertise and add senior leaders to a Consulting team that supported nearly one-third of all sponsor NDA/BLA submissions approved by FDA in 2024.

WAYNE, Pa., July 01, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG. The acquisition adds a broad portfolio of therapeutic products to Teleflex’s portfolio of interventional access products, driving an enhanced global presence in the cath lab. The Vascular Intervention business will also establish Teleflex's global footprint in the fast-growing peripheral intervention market, and provide a channel for Teleflex products that currently have a peripheral indication.

Acquisition bolsters Parsons’ electromagnetic warfare and all-domain solutions for the U.S. defense market

Exchange to Be Headquartered in Nevada, Embracing Current Administration’s Vision for U.S. Cryptocurrency Leadership

Financing co-led by Ferring Ventures S.A. and Apeiron Investment Ltd. with participation from new and existing healthcare-focused institutional investors, including Ally Bridge Group and ADAR1

AI HomeDesign Delivers Scalable Visual Marketing Solution to MIAMI REALTORS®: A Model for MLSs and Brokerages Nationwide

NEW YORK, and AMSTERDAM and OXFORD, United Kingdom, July 01, 2025 (GLOBE NEWSWIRE) --  atai Life Sciences (NASDAQ: ATAI) (“atai”), a clinical-stage biopharmaceutical company on a mission to develop highly effective mental health treatments to transform patient outcomes, and Beckley Psytech Limited (“Beckley Psytech”), a private clinical-stage biopharmaceutical company pioneering the next generation of mental health treatments, today jointly announced positive topline results from the eight-week, quadruple-masked, dose-finding, core stage of the Phase 2b clinical trial evaluating the efficacy and safety of a single dose of BPL-003 (intranasal mebufotenin (5-MeO-DMT) benzoate) in patients with treatment-resistant depression (TRD). The study achieved its primary endpoint as well as all key secondary endpoints. At Day 29, a single 12 mg dose of BPL-003 demonstrated a statistically significant reduction in depressive symptoms, as measured by the Montgomery-Åsberg Depression Rating Scale (MADRS), with a mean decrease of 11.1 points from baseline compared to a 5.8 point reduction in the 0.3 mg comparator group (p = 0.0038). For the key secondary efficacy endpoints, a single 8 mg dose of BPL-003 also showed significant improvement at Day 29, with a mean MADRS score reduction of 12.1 points (p=0.0025 for change vs. 0.3 mg control). Notably, both the 8mg and 12mg doses of BPL-003 showed statistically significant improvements in MADRS scores as early as one day after dosing, with effects generally maintained out to Week 8.

CHATTANOOGA, Tenn., July 01, 2025 (GLOBE NEWSWIRE) -- Syssero, a Workday Services and Innovation Partner, today announced the launch of SyncStream, a new Built on Workday app designed to streamline mergers, acquisitions, and organizational restructuring within Workday. Built in partnership with its sister company Systics, SyncStream blends Syssero’s deep expertise in Workday services with Systics’ automation-forward product development. The result is a sleek, secure app that accelerates organizational alignment—helping customers transition with greater speed, clarity, and confidence.

SHENYANG, China, July 01, 2025 (GLOBE NEWSWIRE) -- On June 27, the opening ceremony of the 11th  "Summer of Hunhe River" Cultural and Art Season kicked off grandly.

Golar LNG's 2nd Quarter 2025 results will be released before the NASDAQ opens on Thursday, August 14, 2025. In connection with this a webcast presentation will be held at 1:00 P.M (London Time) on Thursday August 14, 2025. The presentation will be available to download from the Investor Relations section at www.golarlng.com

Hamilton, Bermuda, July 1, 2025 -- Golar LNG Limited (the “Company”) (NASDAQ: GLNG) announced today the closing of its previously announced offering of 2.75% Convertible Senior Notes due 2030 (the “Notes”), in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company sold $575 million aggregate principal amount of the Notes, including $75 million aggregate principal amount of the Notes sold pursuant to the initial purchasers’ exercise in full of their 30-day option to purchase additional Notes in connection with the offering.

Inmarsat Maritime’s fully managed service has found ready audience among shipping companies seeking power of multiple networks with convenience of single provider

BEIJING, China, July 01, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 36,279 vehicles in June 2025. This brought the Company’s second-quarter deliveries to 111,074. As of June 30, 2025, Li Auto’s cumulative deliveries reached 1,337,810.

Genitourinary Tumor Study Ongoing with Active Screening and Enrollment

A New Milestone in the commercialization of Green Energy Technologies

LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- Shiprock Capital Management Limited (“Shiprock”), a London-based investment management firm focused on Global Distressed and Special Situations, has announced that Eric Ho has joined the firm as Senior Investment Counsel.

REYKJAVIK, Iceland and LONDON, July 01, 2025 (GLOBE NEWSWIRE) --  Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the companies have entered into a supply and commercialization agreement for AVT10, Alvotech’s biosimilar candidate to Cimzia® (certolizumab pegol).

Helsinki, July 01, 2025 (GLOBE NEWSWIRE) -- Finnish nuclear technology company Steady Energy announces the successful completion of its €32 million funding round and will now begin constructing a full-scale pilot plant. With preliminary agreements secured for 15 reactors in Finland and a potential to deliver dozens of reactors in the European Union, Steady Energy is on track to deploy the world’s first commercial nuclear heating plants in the early 2030s. 

MUMBAI, India, July 01, 2025 (GLOBE NEWSWIRE) -- Lumina Datamatics, a strategic partner to global publishers and eCommerce retailers, is delighted to announce that it has been honored with the ET Now Best Organisations to Work 2025 Award on Wednesday, June 25, 2025, at Hotel Sahara Star in Mumbai. Lumina Datamatics was among the top 200 companies shortlisted for the honor out of 1,000 companies that participated, including marquee organizations such as Google India, HDFC Bank Limited, Wipro Limited, Tech Mahindra, Aditya Birla Capital Limited, Hindustan Unilever, Nestle India Limited and Britannia Industries among others.

LONDON, July 01, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Joseph Shipley as a Senior Managing Director within the Strategic Communications segment, where he will lead the firm’s work with private equity clients and their portfolio companies in London and across the Europe, Middle East and Africa (“EMEA”) region.